To assess the biological function of CAPG, three different shRNAs (Supplementary Table 2) were employed to knock down CAPG in three AML cell lines (U937, MV4-11, and Kasumi-1 cells). The gene discussed is CAPG; the disease is acute myeloid leukemia.